GGT5 and cancer: Therefore, when the conditioned media from GGT5-silenced CAFs was used to treat LUAD cells, less cysteine and glutamate were provided for GSH synthesis in cancer cells, which accounted for the slower cell growth and higher drug-sensitivity of cancer cells after treatment the cultures.